This document discusses various aspects of pharmaceutical packaging. It begins by defining primary, secondary, and tertiary packaging. The objectives of packaging include marketing, identification, protection, and convenience. Selection of packaging depends on factors like content stability and compatibility. Common packaging materials include glass, plastic, rubber, metals, and paper. The document then discusses various packaging types like containers, closures, collapsible tubes, and unit dose packaging. It outlines tests for evaluating different packaging materials and provides an overview of FDA regulations for pharmaceutical packaging.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
Selection and evaluation of pharmaceutical packaging materialsTushar Naik
The document discusses the selection and evaluation of pharmaceutical packaging materials. It describes the key factors to consider when selecting packaging, including the drug properties, intended use conditions, and potential interactions. The main packaging materials discussed are glass, plastic, rubber, and metal. Glass types I-IV are outlined based on their chemical resistance. Compatibility tests for packaging include water attack testing of glass and evaluation of plastic containers for leakage, water permeability, and collapsability. Rubber closure testing involves sterility, residue levels, penetrability, and self-sealability. Proper packaging selection and evaluation helps ensure the drug product remains safe, stable and effective throughout its shelf life.
This document discusses the qualification of UV-visible spectrophotometry. It begins by defining qualification as an act or process to ensure something complies with conditions, standards, or requirements. There are four types of qualification: design, installation, operational, and performance. UV-visible spectroscopy is concerned with the ultraviolet and visible regions ranging from 200-780 nm. The document outlines parameters for acceptance procedures and performance qualification of a UV-visible spectrophotometer, including wavelength accuracy, stray light, resolution power, noise, baseline flatness, stability, photometric accuracy, and linearity.
The document discusses the objectives and guidelines of the International Council for Harmonization (ICH) for stability testing of pharmaceutical products. It provides an overview of the key ICH guidelines for stability testing (Q1A-Q1F) and describes the principles of stability testing including establishing re-test periods and shelf lives. It also discusses the different types of stability testing, protocols, study designs like bracketing and matrixing, and key parameters for evaluation.
This document discusses capsules as a dosage form of medication. It provides an introduction to capsules, describing them as solid dosage forms that contain one or more ingredients enclosed in a gelatin shell. The document outlines the advantages of capsules, such as masking unpleasant tastes and being easy to swallow. Disadvantages include some drugs or solutions being unsuitable for capsules. The document also describes various quality control tests for capsules, such as appearance, size, disintegration testing, weight variation, and content uniformity testing. It provides details on procedures for several of these tests.
This document discusses analytical method validation. It defines analytical method validation as providing assurance that an analytical method can consistently and accurately determine the presence or quantity of attributes. The objectives of validation are to obtain consistent, reliable and accurate data. Key parameters that are assessed in validation include specificity, accuracy, precision, linearity, range, limits of detection and quantification, ruggedness and robustness. The validation process involves planning, testing method performance characteristics, selecting validation acceptance criteria, and documenting results in a validation report. Validation is important for analytical methods used in pharmaceutical analysis.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
Selection and evaluation of pharmaceutical packaging materialsTushar Naik
The document discusses the selection and evaluation of pharmaceutical packaging materials. It describes the key factors to consider when selecting packaging, including the drug properties, intended use conditions, and potential interactions. The main packaging materials discussed are glass, plastic, rubber, and metal. Glass types I-IV are outlined based on their chemical resistance. Compatibility tests for packaging include water attack testing of glass and evaluation of plastic containers for leakage, water permeability, and collapsability. Rubber closure testing involves sterility, residue levels, penetrability, and self-sealability. Proper packaging selection and evaluation helps ensure the drug product remains safe, stable and effective throughout its shelf life.
This document discusses the qualification of UV-visible spectrophotometry. It begins by defining qualification as an act or process to ensure something complies with conditions, standards, or requirements. There are four types of qualification: design, installation, operational, and performance. UV-visible spectroscopy is concerned with the ultraviolet and visible regions ranging from 200-780 nm. The document outlines parameters for acceptance procedures and performance qualification of a UV-visible spectrophotometer, including wavelength accuracy, stray light, resolution power, noise, baseline flatness, stability, photometric accuracy, and linearity.
The document discusses the objectives and guidelines of the International Council for Harmonization (ICH) for stability testing of pharmaceutical products. It provides an overview of the key ICH guidelines for stability testing (Q1A-Q1F) and describes the principles of stability testing including establishing re-test periods and shelf lives. It also discusses the different types of stability testing, protocols, study designs like bracketing and matrixing, and key parameters for evaluation.
This document discusses capsules as a dosage form of medication. It provides an introduction to capsules, describing them as solid dosage forms that contain one or more ingredients enclosed in a gelatin shell. The document outlines the advantages of capsules, such as masking unpleasant tastes and being easy to swallow. Disadvantages include some drugs or solutions being unsuitable for capsules. The document also describes various quality control tests for capsules, such as appearance, size, disintegration testing, weight variation, and content uniformity testing. It provides details on procedures for several of these tests.
This document discusses analytical method validation. It defines analytical method validation as providing assurance that an analytical method can consistently and accurately determine the presence or quantity of attributes. The objectives of validation are to obtain consistent, reliable and accurate data. Key parameters that are assessed in validation include specificity, accuracy, precision, linearity, range, limits of detection and quantification, ruggedness and robustness. The validation process involves planning, testing method performance characteristics, selecting validation acceptance criteria, and documenting results in a validation report. Validation is important for analytical methods used in pharmaceutical analysis.
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
Capsules come in both hard and soft gelatin shells that enclose solid or liquid medications. Quality control tests are conducted on empty capsules and finished capsules to ensure uniformity of weight, content of active ingredients, and dissolution. Key tests include uniformity of weight, content of active ingredients, and uniformity of content. Acceptance criteria vary slightly between pharmacopeias but generally require less than 10% deviation from the average weight and 90-110% of the average active content. In-process quality checks are also important to monitor production and identify defects.
This document discusses manufacturing operations and controls to prevent mix-ups and cross contamination. It outlines precautions like proper air handling, segregated areas, and status labeling. Processing of intermediates and bulk products must be documented and checks put in place to ensure quality like verifying identity and yields. Calibration records and batch production and control records are required. Contamination can occur from materials, areas, equipment or people so trained personnel and technical measures like separate production areas are important controls.
IPQC?
Its Need
In-Process Quality Control tests for Tablets
Hardness
Friability
Thickness
Disintegration Time
Weight variation
Content uniformity
Dissolution test
Leakage testing for strip and blister packaging
Photostability testing is performed to evaluate the stability of drug substances and products when exposed to light. It aims to identify necessary precautions to prevent unacceptable changes during manufacturing, formulation, or shelf life. The document discusses factors influencing photostability and provides examples. It outlines the process for photostability testing of both drug substances and products according to ICH guidelines, including presentation of samples, analysis, and judgement of results. Challenges in testing and solutions to ensure accurate light measurements and tight environmental control are also reviewed.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Presentatio on IPQC for Capsules by Akshay Trivedi
Quality control (QC) is a process by which entities review the quality of all factors involved in production. ISO 9000 defines quality control as "A part of quality management focused on fulfilling quality requirements".[1]
This approach places an emphasis on three aspects (enshrined in standards such as ISO 9001)[2][3]:
Elements such as controls, job management, defined and well managed processes,[4][5] performance and integrity criteria, and identification of records
Competence, such as knowledge, skills, experience, and qualifications
Soft elements, such as personnel, integrity, confidence, organizational culture, motivation, team spirit, and quality relationships.
Inspection is a major component of quality control, where physical product is examined visually (or the end results of a service are analyzed). Product inspectors will be provided with lists and descriptions of unacceptable product defects such as cracks or surface blemishes for example.[3]
The quality of the outputs is at risk if any of these three aspec
Modern humans are distinguished from other species by their extensive use of tools to control and adapt to their surroundings. Early stone tools such as anvils had no holes and were not designed as interchangeable parts. Mass production established processes for the creation of parts and system with identical dimensions and design, but these processes are not uniform and hence some customers were unsatisfied with the result. Quality control separates the act of testing products to uncover defects from the decision to allow or deny product release, which may be determined by fiscal constraints.[6] For contract work, particularly work awarded by government agencies, quality control issues are among the top reasons for not renewing a contract.[7]
The simplest form of quality control was a sketch of the desired item. If the sketch did not match the item, it was rejected, in a simple Go/no go procedure. However, manufacturers soon found it was difficult and costly to make parts be exactly like their depiction; hence around 1840 tolerance limits were introduced, wherein a design would function if its parts were measured to be within the limits. Quality was thus precisely defined using devices such as plug gauges and ring gauges. However, this did not address the problem of defective items; recycling or disposing of the waste adds to the cost of production, as does trying to reduce the defect rate. Various methods have been proposed to prioritize quality control issues and determine whether to leave them unaddressed or use quality assurance techniques to improve and stabilize production.[6]
Notable approaches
This document discusses process validation for solid oral dosage forms such as tablets and capsules. It begins by defining process validation and outlining the types, including prospective, concurrent, and retrospective validation. For tablets, it covers validation of raw materials, analytical methods, equipment, and process parameters. For capsules, it discusses validation of the capsule composition, encapsulation process, and quality control tests. The conclusion emphasizes that validation ensures reproducibility and compliance.
The document discusses key considerations for scaling up production of liquid oral dosage forms from pilot plant to commercial scale. Parameters that must be addressed include selection of appropriate mixing and filling equipment based on viscosity and batch size, maintaining uniform temperature and mixing speeds, and ensuring proper filtration and transfer processes. Comprehensive quality control testing is also needed to evaluate characteristics like clarity, pH, viscosity and drug content uniformity during scale up. Careful attention to process variables can help successfully transfer liquid oral formulations from small to large scale production.
This document discusses in-process quality control (IPQC) tests for ointments. It describes IPQC as the process of controlling quality parameters during manufacturing from raw materials to final packaging. It then lists and describes 11 common IPQC tests conducted on ointments, including tests for appearance, drug content, pH, sensitivity, spreadability, absorption rate, extrudability, sterility, viscosity, medicament release rate, and uniformity of weight. The tests are designed to ensure the quality, safety and efficacy of ointment products during production.
This document provides guidance on validating a liquid filling and sealing machine. It discusses the key stages of validation including user requirement specification, design qualification, installation qualification, operational qualification, and performance qualification. The performance qualification section provides specific tests to validate the machine's weight variation, filling volume accuracy, particle contamination levels, leak testing, and oxygen content. Requalification of the machine is recommended on a defined schedule or after any changes to ensure continued proper operation.
The document discusses in-process quality control (IPQC) for parenteral products. IPQC involves controlling manufacturing procedures from raw materials to finished product release. Key IPQC tests for parenterals include clarity testing to detect particulate matter using visual or automated methods, leakage testing of packaging, testing fill volume and pH, and sterility testing. The document outlines various physical, chemical, biological, and microbiological tests performed during IPQC to ensure product quality.
This document summarizes WHO guidelines for assessing the quality, safety, and efficacy of herbal medicines. The guidelines provide criteria for evaluating herbal medicines, including assessing crude plant materials, plant preparations, finished products, stability, safety, efficacy, intended use, product information, and utilization of the guidelines. The objective is to help regulatory authorities and manufacturers properly evaluate herbal medicines.
This document discusses the scale-up considerations for producing parenteral drugs on a pilot plant scale. It describes the key unit operations in parenteral production as mixing, sterilization, filtration, filling and sealing. For each unit operation, parameters that must be considered for scale-up are identified, such as tank size and type, impeller design, membrane size, filling rate and container size. Maintaining sterility and avoiding issues like precipitation or clogging are important challenges addressed during scale-up. Quality control tests are used to evaluate the scaled processes. Proper scale-up allows efficient transition from laboratory to commercial production of injectable drug products.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
This document discusses the qualification of manufacturing equipment. It explains that equipment qualification is necessary to ensure equipment works correctly and produces reliable results. There are four types of qualification: design, installation, operational, and performance. Design qualification defines equipment specifications. Installation qualification confirms proper installation. Operational qualification verifies equipment functions as specified. Performance qualification demonstrates consistent performance under routine use. The document then provides details on specific qualification procedures for dry powder mixers and fluidized bed dryers.
IPQC cover the entire chain of operations from the receipt of raw material in the warehouse to the release of finished products from the warehouse for distribution and or sale. IPQC is a process where quality of a product is ensured that it meets the standard according to regulatory authority guidline.
This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
Capsules come in both hard and soft gelatin shells that enclose solid or liquid medications. Quality control tests are conducted on empty capsules and finished capsules to ensure uniformity of weight, content of active ingredients, and dissolution. Key tests include uniformity of weight, content of active ingredients, and uniformity of content. Acceptance criteria vary slightly between pharmacopeias but generally require less than 10% deviation from the average weight and 90-110% of the average active content. In-process quality checks are also important to monitor production and identify defects.
This document discusses manufacturing operations and controls to prevent mix-ups and cross contamination. It outlines precautions like proper air handling, segregated areas, and status labeling. Processing of intermediates and bulk products must be documented and checks put in place to ensure quality like verifying identity and yields. Calibration records and batch production and control records are required. Contamination can occur from materials, areas, equipment or people so trained personnel and technical measures like separate production areas are important controls.
IPQC?
Its Need
In-Process Quality Control tests for Tablets
Hardness
Friability
Thickness
Disintegration Time
Weight variation
Content uniformity
Dissolution test
Leakage testing for strip and blister packaging
Photostability testing is performed to evaluate the stability of drug substances and products when exposed to light. It aims to identify necessary precautions to prevent unacceptable changes during manufacturing, formulation, or shelf life. The document discusses factors influencing photostability and provides examples. It outlines the process for photostability testing of both drug substances and products according to ICH guidelines, including presentation of samples, analysis, and judgement of results. Challenges in testing and solutions to ensure accurate light measurements and tight environmental control are also reviewed.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Presentatio on IPQC for Capsules by Akshay Trivedi
Quality control (QC) is a process by which entities review the quality of all factors involved in production. ISO 9000 defines quality control as "A part of quality management focused on fulfilling quality requirements".[1]
This approach places an emphasis on three aspects (enshrined in standards such as ISO 9001)[2][3]:
Elements such as controls, job management, defined and well managed processes,[4][5] performance and integrity criteria, and identification of records
Competence, such as knowledge, skills, experience, and qualifications
Soft elements, such as personnel, integrity, confidence, organizational culture, motivation, team spirit, and quality relationships.
Inspection is a major component of quality control, where physical product is examined visually (or the end results of a service are analyzed). Product inspectors will be provided with lists and descriptions of unacceptable product defects such as cracks or surface blemishes for example.[3]
The quality of the outputs is at risk if any of these three aspec
Modern humans are distinguished from other species by their extensive use of tools to control and adapt to their surroundings. Early stone tools such as anvils had no holes and were not designed as interchangeable parts. Mass production established processes for the creation of parts and system with identical dimensions and design, but these processes are not uniform and hence some customers were unsatisfied with the result. Quality control separates the act of testing products to uncover defects from the decision to allow or deny product release, which may be determined by fiscal constraints.[6] For contract work, particularly work awarded by government agencies, quality control issues are among the top reasons for not renewing a contract.[7]
The simplest form of quality control was a sketch of the desired item. If the sketch did not match the item, it was rejected, in a simple Go/no go procedure. However, manufacturers soon found it was difficult and costly to make parts be exactly like their depiction; hence around 1840 tolerance limits were introduced, wherein a design would function if its parts were measured to be within the limits. Quality was thus precisely defined using devices such as plug gauges and ring gauges. However, this did not address the problem of defective items; recycling or disposing of the waste adds to the cost of production, as does trying to reduce the defect rate. Various methods have been proposed to prioritize quality control issues and determine whether to leave them unaddressed or use quality assurance techniques to improve and stabilize production.[6]
Notable approaches
This document discusses process validation for solid oral dosage forms such as tablets and capsules. It begins by defining process validation and outlining the types, including prospective, concurrent, and retrospective validation. For tablets, it covers validation of raw materials, analytical methods, equipment, and process parameters. For capsules, it discusses validation of the capsule composition, encapsulation process, and quality control tests. The conclusion emphasizes that validation ensures reproducibility and compliance.
The document discusses key considerations for scaling up production of liquid oral dosage forms from pilot plant to commercial scale. Parameters that must be addressed include selection of appropriate mixing and filling equipment based on viscosity and batch size, maintaining uniform temperature and mixing speeds, and ensuring proper filtration and transfer processes. Comprehensive quality control testing is also needed to evaluate characteristics like clarity, pH, viscosity and drug content uniformity during scale up. Careful attention to process variables can help successfully transfer liquid oral formulations from small to large scale production.
This document discusses in-process quality control (IPQC) tests for ointments. It describes IPQC as the process of controlling quality parameters during manufacturing from raw materials to final packaging. It then lists and describes 11 common IPQC tests conducted on ointments, including tests for appearance, drug content, pH, sensitivity, spreadability, absorption rate, extrudability, sterility, viscosity, medicament release rate, and uniformity of weight. The tests are designed to ensure the quality, safety and efficacy of ointment products during production.
This document provides guidance on validating a liquid filling and sealing machine. It discusses the key stages of validation including user requirement specification, design qualification, installation qualification, operational qualification, and performance qualification. The performance qualification section provides specific tests to validate the machine's weight variation, filling volume accuracy, particle contamination levels, leak testing, and oxygen content. Requalification of the machine is recommended on a defined schedule or after any changes to ensure continued proper operation.
The document discusses in-process quality control (IPQC) for parenteral products. IPQC involves controlling manufacturing procedures from raw materials to finished product release. Key IPQC tests for parenterals include clarity testing to detect particulate matter using visual or automated methods, leakage testing of packaging, testing fill volume and pH, and sterility testing. The document outlines various physical, chemical, biological, and microbiological tests performed during IPQC to ensure product quality.
This document summarizes WHO guidelines for assessing the quality, safety, and efficacy of herbal medicines. The guidelines provide criteria for evaluating herbal medicines, including assessing crude plant materials, plant preparations, finished products, stability, safety, efficacy, intended use, product information, and utilization of the guidelines. The objective is to help regulatory authorities and manufacturers properly evaluate herbal medicines.
This document discusses the scale-up considerations for producing parenteral drugs on a pilot plant scale. It describes the key unit operations in parenteral production as mixing, sterilization, filtration, filling and sealing. For each unit operation, parameters that must be considered for scale-up are identified, such as tank size and type, impeller design, membrane size, filling rate and container size. Maintaining sterility and avoiding issues like precipitation or clogging are important challenges addressed during scale-up. Quality control tests are used to evaluate the scaled processes. Proper scale-up allows efficient transition from laboratory to commercial production of injectable drug products.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
This document discusses the qualification of manufacturing equipment. It explains that equipment qualification is necessary to ensure equipment works correctly and produces reliable results. There are four types of qualification: design, installation, operational, and performance. Design qualification defines equipment specifications. Installation qualification confirms proper installation. Operational qualification verifies equipment functions as specified. Performance qualification demonstrates consistent performance under routine use. The document then provides details on specific qualification procedures for dry powder mixers and fluidized bed dryers.
IPQC cover the entire chain of operations from the receipt of raw material in the warehouse to the release of finished products from the warehouse for distribution and or sale. IPQC is a process where quality of a product is ensured that it meets the standard according to regulatory authority guidline.
This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.
This document discusses the selection and evaluation of pharmaceutical packaging materials. It begins by defining packaging and its purposes of providing protection, identification, convenience, and compliance for products. Key factors in selecting packaging materials include the type of container, product characteristics, and characteristics of the materials themselves like barrier properties and FDA approval. Common container materials like glass, plastic, and metal are described along with their advantages. The document also discusses evaluating packaging materials through tests like leakage tests, collapsibility tests, and permeability tests to ensure suitability for drug products.
This document discusses quality control tests for pharmaceutical packing materials. It describes the different types of primary, secondary, and tertiary packing materials used in the pharmaceutical industry. It focuses on quality control tests for various container materials like glass and plastic. Some key tests discussed for glass containers include chemical resistance testing, hydrolytic resistance testing, surface etching testing, and light transmission testing. For plastic containers, leakage testing, collapsibility testing, clarity of aqueous extract testing, and non-volatile residue testing are described. The document provides details on procedures and acceptance criteria for many of these important quality control tests.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common packaging materials include glass, plastic, paper, and boards. Quality control tests for glass containers include chemical resistance via powdered glass and water attack tests. Tests are also described for plastic containers, including clarity of extract and non-volatile residue. The document concludes that testing packaging materials is important to ensure the quality, stability, and efficacy of drug products.
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are described for checking properties like resistance to heat and pressure. Quality control tests for closures ensure sterility, lack of fragmentation, and proper sealing. These tests are important to ensure the packaging protects the drug product during storage, transport, and use.
Quality control test for containers and closuresHenisha Patel
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are also described for closures, including fragmentation test, sterility test, and tests for properties like pH and reducing substances of aqueous extracts of closures. Various types of primary, secondary, and tertiary packaging are also mentioned, along with quality control tests for blister packs and strips to check for proper sealing and prevention of moisture ingress.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common materials used include glass, plastic, rubber, and paper. Quality control tests are described for glass including powdered glass and water attack tests. Plastic container tests include leakage, collapsibility, water vapor permeability, and transparency. Rubber closure tests include fragmentation, self-sealability, extractive, and compatibility testing. Proper packaging protects pharmaceutical products and quality testing ensures the materials are suitable for drug products.
This document summarizes quality control tests for various pharmaceutical packaging materials including containers, closures, and secondary packaging. It discusses tests for glass, plastic, metal containers as well as rubber, plastic, and metal closures. Specific tests covered include chemical resistance, hydrolytic resistance, arsenic, thermal shock, internal bursting pressure, leakage, transparency, water vapor permeability, and more. Flexible packaging materials like polyethylene, cast polypropylene, bi-oriented polypropylene, polyester, and polyamide are also summarized. The document aims to present an overview of important quality control testing for ensuring the safety and integrity of pharmaceutical packaging.
Selection and Evaluation of Pharmaceutical packaging materials and.pptxAbhishekVinod8
The document discusses various packaging materials used in the pharmaceutical industry including glass, plastic, and metal containers as well as different types of closures. It provides details on the properties, types, evaluation, and testing of these packaging materials to ensure they are suitable for holding pharmaceutical products and meeting regulatory standards. Selection of the appropriate packaging material is based on factors like the route of administration, physical form of the product, stability requirements, and cost considerations.
EVULATION OF PHARMACUTICAL PACAKGING MATERIALS/EVULATION PARAMETERS OF PAKAGI...Ashwani Kumar Singh
This document discusses the evaluation of various packaging materials used for pharmaceutical products. It describes the key characteristics packaging must have including protecting the product from environmental factors while being non-reactive, non-toxic, and FDA approved. Common packaging materials like glass, plastic, and metal are outlined. Specific tests are provided to evaluate each material for qualities like chemical resistance, water permeability, and fragmentation resistance to ensure product safety and stability.
This document discusses quality control tests for various pharmaceutical packaging materials. It provides details on tests for glass containers, including chemical resistance via powdered glass and water attack tests. It also describes tests for closures, such as sterility and fragmentation testing. Further tests are outlined for packaging materials like collapsible tubes, metallic tins, strips, blisters, paper and board. The document references additional sources for information on pharmaceutical packaging and quality control testing.
PACKAGING MATERIAL QUALITY CONTROL TEST AND OPERATION.pdfMayuriPawar98
packaging operation in pharmaceutical industry and material used types and quality control tests,types of container closure system ,recent trends in pharmaceutical packaging
This document discusses quality control tests for packaging materials used in the pharmaceutical industry. It begins with definitions of packaging, quality control, and the different categories of packaging materials. It then describes common materials used for primary packaging like containers and closures, and secondary packaging. The rest of the document outlines specific quality control tests performed on these materials, including chemical resistance testing, hydrolytic resistance testing, and tests for containers, closures, and secondary packaging materials.
This document discusses quality control tests for various pharmaceutical packaging materials. It provides details of tests for glass containers, closures, collapsible tubes, metallic tins, strips, blisters, paper and board. Tests described include chemical resistance of glass, hydrolytic resistance, arsenic test, thermal shock test, leakage test, sterility test, fragmentation test, self-sealability, pH and reducing substances tests for closures. Tests are also provided for leakage, flexibility and lacquer compatibility of collapsible tubes and dimensional checks for metallic tins. The document lists references for further information.
This document provides quality control tests for various pharmaceutical packaging materials including glass containers, closures, metallic tins, strips, blisters, paper and board. It describes tests for chemical resistance, hydrolytic resistance, thermal shock resistance, and arsenic content for glass containers. For closures, tests are provided for sterility, fragmentation, self-sealability, pH and reducing substances of aqueous extracts. It also outlines dimensional checks, leakage testing and lacquer curing tests for collapsible tubes and checks for cleanliness and dimensions for metallic tins. Vacuum desiccator testing is described to check for leakage in strips and blister packages. Finally, it lists references for further information on packaging testing.
This document discusses various materials used for pharmaceutical packaging and equipment construction. It describes common container types like well-closed, single and multi-dose, light-resistant, and aerosol containers. Primary, secondary and tertiary packaging are defined. Common materials like glass, plastic, rubber, metals and paper are outlined. Specific plastics like polyethylene, PVC, and polystyrene are detailed. Closures like screw caps, crowns and friction fits are summarized. Standards for glass containers are provided.
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...himanshu kamboj
b pharma 6th sem
pharmaceutical quality assurance
Introduction
Types of pharmaceutical packaging
Packaging materials
Quality control test for plastic
Quality control test for closures
Quality control of collapsible tubes
Quality control of metallic tins
QC test for secondary packaging materials
Pharmaceutical packaging serves several important functions:
1) It protects drugs from external environmental factors like light, moisture, and contamination.
2) Packaging identifies drug products, provides instructions for proper use, and ensures safety and efficacy.
3) Packaging types include bottles, blister packs, vials, and other containers/closures that are evaluated through testing to ensure sterility, integrity, and that they do not interact with drug contents.
This document discusses depreciation accounting concepts, objectives, causes, and methods. It defines depreciation as the allocation of an asset's cost over its useful life. Objectives of depreciation include matching revenues and expenses to determine profit, and recovering an asset's cost over the periods it benefits the company. Causes of depreciation include wear and tear, aging, and obsolescence. Common depreciation methods include straight-line, written down value, and sum of years digits. The document also covers depreciation calculations, accounting entries, and policies for different asset types.
The document discusses the structure and functions of cell membranes. It introduces the fluid-mosaic model and defines key terms related to pH, acids, bases, and buffers. pH measures the hydrogen ion concentration in solutions and indicates whether they are acidic or alkaline. Buffers resist changes in pH and their effectiveness depends on the environment's pH. The passage also notes that blood pH is normally between 7.35-7.45, and that conditions outside this range, like acidosis or alkalosis, require compensatory mechanisms.
This document summarizes key concepts about carbohydrates. It defines monosaccharides, disaccharides, oligosaccharides, and polysaccharides. It describes the basic composition of carbohydrates including aldoses, ketoses, D and L designations. It explains sugar nomenclature and glycosidic bonds. Examples of specific carbohydrates are given including maltose, cellobiose, sucrose, lactose, amylose, amylopectin, glycogen, cellulose, hyaluronate, heparin, and heparan sulfate. Glycolysis and the citric acid cycle are also summarized.
The document discusses amino acids and protein structure and function. It begins by describing how amino acids are linked by peptide bonds to form polypeptide chains and proteins. It then explains that amino acids can be essential, nonessential, or conditionally essential depending on whether they must be obtained from diet. The document also discusses protein structure, the uses of proteins in the body, and how the body breaks down and uses amino acids for energy or biosynthesis through various pathways.
Vitamins and minerals are essential nutrients that assist many chemical reactions in the body. Vitamins are classified as either fat-soluble (A, D, E, K) or water-soluble (B, C). They help with vision, tissue growth, bone development, and carbohydrate metabolism. Minerals like calcium, phosphorus, and iron are important components of bones and teeth, while others like sodium and potassium help regulate fluid balance and muscle function. Deficiencies can cause conditions like rickets, anemia, or goiter. The body absorbs and stores vitamins and minerals differently, with fat-soluble vitamins accumulating more easily.
Lipids are diverse molecules that include fatty acids, triglycerides, phospholipids, and steroids. They are insoluble in water due to their nonpolar characteristics. Lipids serve important structural and energy storage functions in cells. The main types of lipids are fatty acids, triglycerides, sterols like cholesterol, and phospholipids. Fatty acids can be saturated, monounsaturated, or polyunsaturated depending on the number of double bonds in their hydrocarbon chains. Triglycerides are composed of fatty acids esterified to a glycerol backbone and serve as long-term energy stores. Cholesterol is an important steroid lipid involved in membrane structure and synthesis of hormones and vitamins. Atheros
IPQC tests are important quality control checks performed during the manufacturing of tablets, capsules, and ointments. For tablets, key tests include weight variation, disintegration, dissolution, drug content, hardness, and friability. Tests for capsules include uniformity of content, disintegration, weight variation, and dissolution. Common tests for ointments are not described. IPQC aims to detect errors, minimize human error, and ensure quality at each stage of production according to established procedures.
This document discusses various types of abortion, including spontaneous, threatened, inevitable, complete, incomplete, missed, septic, and habitual abortion. It defines abortion as the expulsion of the fetus weighing less than 1000g before 28 weeks gestation. Spontaneous abortion is the involuntary loss of pregnancy before 28 weeks. Causes can be maternal, fetal, or immunological factors. Treatment depends on the type but may include bed rest, medication, or surgical evacuation of the uterus. The document also covers medical termination of pregnancy (legal abortion) and various methods used in the first and second trimesters.
Mr. X, an 80-year-old male, presented with altered mental status, irrelevant speech, decreased urine output, dry skin, nausea, and vomiting for the past two days. This suggests fluid volume deficit (hypovolemia) likely due to fluid losses from vomiting and diarrhea. Physical assessment should include vital signs, skin turgor, capillary refill time, orthostatic blood pressure, and urine specific gravity. Laboratory tests may show increased BUN and hematocrit. Intravenous isotonic fluids should be given to expand plasma volume along with electrolyte replacement as needed. Nursing care involves monitoring intake and output, daily weights, and signs of circulatory compromise.
The third stage of labor begins after birth and ends with delivery of the placenta, usually within 20 minutes. Complications include postpartum hemorrhage from uterine atony, retained placenta, shock, pulmonary embolism, and rare cases of uterine inversion. Active management with oxytocin administration within 1 minute of birth reduces risks by helping the uterus contract and speeding delivery of the placenta.
This document discusses quality control procedures for raw materials, in-process controls, and finished drug products. It outlines various tests and checks done at different stages of production to ensure product quality and purity. These include sampling and testing of incoming raw materials, in-process checks of attributes like tablet weight and size, and final testing of finished products prior to release. The goals of quality control/assurance programs are to ensure consistent active ingredient amounts within limits, use of ingredients meeting specifications, minimized variability between doses, and high purity and stability of finished products.
This document discusses preoperative nursing care for surgical patients. It covers assessing patients' medical history and surgical risk factors, obtaining informed consent, providing preoperative education on postoperative expectations like pain management and breathing exercises, and establishing nursing diagnoses like anxiety, fear, and knowledge deficits. The goals are to optimize patients' health for surgery and reduce postoperative complications through assessment, teaching, and supportive nursing measures.
A mobile coronary care unit (MCCU) is an ambulance equipped to provide intensive cardiac care and transport critically ill cardiac patients to the hospital. The MCCU has cardiac monitoring equipment, life-saving medications, and a team of paramedics, nurses with cardiac training. Patients receive the same level of care onboard as in a hospital coronary care unit. The MCCU evaluates patients, provides emergency treatment, and transports patients directly to the hospital coronary care unit for further treatment and testing.
HPLC, or high performance liquid chromatography, is an analytical technique used to separate compounds in a mixture. It works by injecting a sample onto a column containing a stationary phase, which causes the different compounds in the mixture to pass through the column at different rates based on their interactions with the stationary and mobile phases. This separation allows for the individual quantification and identification of compounds in the sample. Key aspects of HPLC include the use of high pressure to allow for small particle sizes in the stationary phase, which enables better separation. Common applications of HPLC include the simultaneous analysis of multiple compounds, analysis of compounds at low concentrations, and fractionation of samples for further analysis or purification.
Spontaneous abortion, also known as miscarriage, is the clinically recognized loss of a pregnancy before 20 weeks gestation. It is the most common complication of early pregnancy, with a frequency that decreases with increasing gestational age. Risk factors include advanced maternal age, previous spontaneous abortion, smoking, certain medications, extremes of maternal weight, and maternal infections. Spontaneous abortions are usually due to fetal abnormalities but can also result from maternal factors. Presenting symptoms include vaginal bleeding and pelvic pain. Diagnosis involves pelvic examination, ultrasound criteria, and serial beta hCG levels. Management depends on the classification of abortion as threatened, incomplete, or missed and may involve expectant monitoring, medical treatment, or surgical evacuation
The document describes a smart glove system for deaf and mute people that uses flex sensors and an Arduino board to translate sign language gestures into text or speech. The system captures gestures using flex sensors on a glove connected to an Arduino board. The Arduino board transforms the gestures into text or speech using a text-to-speech converter. An Android app is also proposed to receive the translated messages and output them as voice, allowing deaf people to communicate with others. The system aims to provide an easy and portable way for speech and hearing impaired individuals to communicate.
The document discusses various aspects of accounting for small businesses, including:
- Types of business ownership like sole proprietorships, partnerships, corporations, and LLCs.
- Accounting systems like single entry and double entry accounting. Single entry records transactions only once while double entry uses debits and credits.
- Accounting methods like cash basis and accrual basis for recording revenues and expenses.
- Features of single entry accounting including its simplicity but incompleteness compared to double entry accounting. Methods for determining profit under single entry using net worth or conversion methods are also outlined.
The Joint Commission (TJC) defines a sentinel event as an unexpected occurrence involving death or serious physical or psychological injury. When a sentinel event occurs, hospitals must conduct a root cause analysis within 45 days to determine what factors contributed to the event. Various government agencies have defined lists of specific reportable sentinel events that healthcare facilities must report. Some examples include surgery on the wrong patient, foreign objects left in the body after surgery, and severe neonatal jaundice. Identifying and analyzing these sentinel events helps improve patient safety and quality of care.
It helps in achieving group goals.
2.
Continuous Process: It is a continuous process as activities keep changing.
3.
Horizontal & Vertical: It exists both horizontally & vertically in an organization.
4.
Interdependence: Activities are interdependent & require synchronization.
5.
Achieves Unity of Action: It ensures unity of action & effort.
Importance of Coordination:
1.
Achieves Organizational Goals
2.
Prevents Duplication of Work
3.
Ensures Unity of Command
4.
Facilitates Specialization
5.
Redu
2. Introduction:
What is packag?
It is art and science of preparing articles for transport, storage,
display and use.
The selection of a package therefore begins with a
determination of the product’s physical and chemical
characteristics, its protective needs, and its marketing
requirements.
2
3. Objectives of packaging
Marketing potential and presentation of packaging.
Identification , information, protection.
Preserves integrity of product.
Convenience, compliance and containment during storage.
Brand identity.
3
4. Selection of type of pack depends upon its :
Content stability
Content reactivity with packaging material(drug compatibility).
Accessibility of pack to user.
Packaging process.
Regularity ,legal, quality issues.
4
5. TYPES OF PACKAGING:
Primary packaging is the material that envelopes the product and holds it. This
usually is the smallest unit of distribution or use and is the package which is in
direct contact with the contents.
Primary packaging :
5
7. Tertiary packages:
Is used for bulk handling, warehouse storage and transport shipping.
The most common form is a palletized unit load that packs tightly into
the container.
7
9. CLOSURE:
A closure is the part of the package which prevent the contents from
escaping and allow no substance to enter the container.
Closures are available in five basic designs
1. Screw on, threaded or lug
2. Crimp on(crowns)
3. Press on(snap)
4. Roll on and
5. Friction
9
10. CLOSURE LINERS:
A liner may be defined as any material that inserted in a cap to effect a seal
between the closure and the container.
It is of two types:
1. Homogeneous liners
These are one piece liners available as disk or a ring of rubber or plastic.
It can be withstand high temperature sterilization.
2. Heterogeneous liners
These are composed of layers of different materials chosen for specific
requirements.
It consists of facing and backing. Facing is in contact with product and backing
provides questioning effect. 10
14. MATERIALS USED FOR MAKING OF CONTAINERS:
GLASS-
e.g.bottles,vials,ampules,syringes,i.v containers, aerosol containers.
PLASTIC-
e.g.bottlespouches,tapes,tubes,aerosolcontainers,laminates.
14
16. Paper or cardboard:
e.g. secondary packaging
labels,inserts,displayunits,pouches,laminates,cartons,carrogated
boxes,foils,paper drums
16
17. Composition of glass:
Glass is composed principally of sand, soda ash, lime stone and
cullet.
Sand is almost pure sillica,soda ash is sodium carbonate, lime
stone is calcium carbonate.
Cullet is broken glass that is mixed with the batch and acts as
fusion agent for the entire mixture.
GLASS CONTAINERS:
17
18. TYPES OF GLASS
Type I—Highly resistant borosilicate glass.
Type II—Treated soda lime glass.
Type III—soda lime glass.
NP—soda glass (non parenteral usage).
18
20. EVALUATION OF PACKAGING
MATERIALS
TESTS FOR GLASS CONTAINERS:
1) Powdered glass test
2) Water attack test
Preparation of specimen for powdered glass test:
Rinse 6 or more containers and dry them
Crushed in to fragments
Divide 100gms of coarsely crushed glass in to
three equal parts 20
21. place 1 portion in a mortar
Crush further by striking 3 or 4 blows with hammer
Nest the sieves (# 20,40 at least)
Empty the mortar in to sieve 20
Shake the sieves and remove the glass particles from # 20 and 40
Crush them again and sieve them
Transfer the retained portion on # 50
21
22. Spread the specimen on a glazed paper
and remove iron particles with the help of magnet
Wash with 6 portions of 30ml acetone
Dry the contents for 20mins at 140oc
Transfer to weighing bottle and cool in a desiccator.
Final specimen should be used in powdered glass test
22
23. 1) POWDERED GLASS TEST: (according to USP volume 27)
Transfer 10gms of prepared specimen in a 250ml conical flask
digested previously with high purity water in a bath at 90o c
Add to conical flask containing 50ml high purity water
Cap all the flasks and auto clave
Adjust temperature to 150oc
Cold the temperature to 121oc for 30mins
Cool the flasks under running water
23
24. Wash the residue powdered glass(4 times with 15ml purity water)
Add the decanted washings to main portion.
add five drops of methyl red solution.
Titrate immediately with 0.02N sulphuric acid.
Record the volume of 0.02N sulphuric acid.
Volume does not exceed i.e. indicated in the USP as per the type
of glass concerned
24
25. 2).WATER ATTACK TEST:(USP)
rinse 3 or more containers with high purity water
fill each container to 90%of its over flow capacity
cap all the flasks and autoclave for 60mints
empty the contents and cool the contents in 250ml conical
flasks to a volume of 100ml.add 5 drops of methyl red solution
titrate with 0.02N sulphuric acid while warm
record the volume of 0.02Nsulphuric acid consumed
volume should not exceed as indicated in USP as for type of
glass
25
26. PLASTIC CONTAINERS:
Plastics are synthetic polymers of high molecular weight.
Plastics as packaging have proved useful for a number of
reasons, including the ease with which they can be formed,
their high quality and the freedom to design.
Plastic containers are extremely resistant to breakage and
offer safety consumers. Two types of plastic are available in
market.
26
27. Thermoplastic type :-
On heating, they are soften to viscous fluid which hardens again
on cooling.
e.g. polyethylene ,PVC ,Polystyrene, polypropylene, Polyamide,
Polycarbonate.
Thermosetting type :-
When heated , they may become flexible but they do not become
liquid.
Phenol formaldehyde ,urea formaldehyde, melamine
formaldehyde
TYPES OF PLASTICS:
27
28. DRUG-PLASTIC CONSIDERATIONS
A packaging system must protect the drug without altering the
composition of the product until the last dose is removed.
Drug-plastic considerations have been divided into five categories:
1. Permeation
2. Leaching
3. Sorption
4. Chemical reaction
5. Alteration 28
29. TESTS FOR PLASTIC CONTAINERS
1.Leakage test for plastic containers(non injectables and
injectables 1996 IP):
fill 10 plastic containers with water and fit the closure
keep them inverted at room temperature for 24 hrs
no sign of leakage should be there from any container
29
30. 2.WATER PERMEABILITY TEST FOR PLASTIC
CONTAINERS(INJECTABLE PREPARATIONS IP 1996):
fill 5 containers with nominal volume of water and sealed
weigh each container
allow to stand for 14 days at relative humidity of 60% at 20-250C
reweigh the container
loss of weight in each container should not be more than 0.2%
30
31. COLLAPSIBLE TUBES
Metals:
The collapsible metal tube is an attractive container that permits
controlled amounts to be dispensed easily, with good reclosure,and
adequate protection of the product.
It is light in weight and unbreakable and lends itself to high speed
automatic filling operations.
Any ductile metal that can be worked cold is suitable for collapsible
tubes, but the most commonly used are tin, aluminium and lead. Tin is
most expensive and lead is cheapest.
31
32. RUBBER:
Rubber is used mainly for the construction of closure meant for
vials, transfusion fluid bottles, dropping bottles and as washers in
many other types of product.
BUTYL RUBBER:
Advantages:
Permeability to water vapor .
Water absorption is very low.
They are relatively cheaper compared to other synthetic rubbers.
Disadvantages:
Slow decomposition takes place above 1300C.
Oil and solvent resistance is not very good.
32
33. NITRILE RUBBER:
Advantages:
Oil resistant due to polar nitrile group.
Heat resistant.
Disadvantages:
Absorption of bactericide and leaching of extractives are considerable.
CHLOROPRENE RUBBERS:
Advantages:
Oil resistant.
heat stability is good.
33
35. TESTS FOR RUBBER/RUBBER CLOSURES
1.FRAGMENTATION TEST(IP 1996):
place a volume of water corresponding to nominal volume-4ml in
each of 12 clean vials
close vial with closure and secure caps for 16hrs
pierce the closure with number 21 hypodermic needle(bevel angle
of 10 to 140c)and inject 1ml water and remove 1ml air
repeat the above operation 4 times for each closure
count the number of fragments visible to naked eye
Total number of fragments should not be more than 10
35
36. 2.SELF SEALABILITY TEST FOR RUBBER CLOSURES
APPLICABLE TO MULTI DOSE CONTAINERS ONLY(IP
1996):
fill 10 vials with water to nominal volume and close the
vials with closures
pierce the cap and closures 10 times at different places
with no 21 syringe needle
immerse the vials in 0.1 %W/v solution of methylene
blue under reduced pressure
restore the nominal pressure and keep the container for
30 min and wash the vials
none of the vial should contain traces of colored
solution 36
37. TAMPER RESISTANT PACKAGING:
The requirement for tamper resistant packaging is now one of the
major considerations in the development of packaging for
pharmaceutical products.
Tamper resistant package is one having an indicator to entry in
which, if breached or missing, can reasonably be expected to provide
visible evidence to consumers that tampering has occurred.
37
38. FDA approves the following configurations as tamper resistant
packaging:
1. Film wrappers
2. Blister package
3. Strip package
4. Bubble pack
5. Shrink seals and bands
6. FOil, paper, plastic pouches
7. Bottle seals
8. Tape seals
9. Breakable caps
10. Aerosol containers
38
39. FDA REGULATIONS
When the FDA evaluates a drug, the agency must be firmly
convinced that the package for a specific drug will preserve the
drug’s efficacy as well as its purity, identity, strength and quality
for its entire shelf life.
The FDA does not approve containers as such, but only the
materials used in the container . A list of substances considered
``Generally Recognised As Safe’’ (GRAS) has been published
by the FDA.
39
40. FDA Regulations for Tablets and Capsules
Description: Overall general
description of container
closure system, plus:
For Each Packaging Component:
Name, product code, manufacturer.
Materials of construction.
Description of any addition treatments.
Suitability:
Protection: Light exposure .
Moisture permeation.
Seal integrity or leak tests for
unit-dose packaging.
Safety: (for each material of construction, as
appropriate)
Chemical composition of all plastics,
elastomers, adhesives, etc.
For tablets, capsules, and powders,
appropriate reference to the indirect food
additive regulation may be submitted.
For rayon and cotton fillers, data from USP
monographs. For non-USP materials, data
acceptance criteria should be provided.
For desiccants and other absorbent
materials: the size and shape should differ
from that of the dosage form.
40
41. Description: Same as for tablets and capsules.
Suitability :Protection: Light exposure
Reactive gases(e.g., oxygen)
Solvent loss
Moisture permeation
Microbial contamination
Seal integrity or leak testing of tubes and
unit dose containers .
Safety: (for each material of composition, as
appropriate)
Chemical composition of all plastics,
elastomers, adhesives, etc.
For topical drug products (plastic
coatings for metal tubes), and plastic
drug delivery system components:
USP Containers testing.
For topical delivery systems:
appropriate reference to indirect food
additive regulations.
41
42. CONCLUSION :
Packaging is one of the most important part of pharmaceutical
industries .
Quality maintenance is major role played by packaging
material.
Along with that it gives pharmaceutical elegance and
convenience to user to product.
Many a times the packaging is may become a ideal unique
identification for some of brand in market.
Quality control of such important part is also a vary valuable
work .
42
43. References:
Leon Lachman , Herbert A. Liberman , The Theory & Practice Of Industrial
Pharmacy. Pg. 711-732
Dean DA, Evans ER, Hall H. Pharmaceutical packaging technology
Pg:210-65.
Remington. The Science and Practice of Pharmacy, Vol-1;Pg:1047-10 .
Howard C. Ansell Loyd V. Allen, Pharmaceutical dosage forms, Pg. 67-91.
N.k. Jain Pharmaceutical product development pg no 341-378
Cooper and Gunn’s –dispensing for pharmaceutical students pg no13-22
Michael E. Aulton the design and manufacturing of medicines no 626-639
Copper and Gunn's tutorial pharmacy Materials of plant pharmaceutical
plant construction .Pg no
R.M.MEHTA Packaging materials Pharmaceutics-I Pg no
Indian Pharmacopiea,2007,Vol-1;Pg:599-25
Encyclopedia of Packaging Technology",
http://www.pharmaceutical-technology.com.
43